Have a personal or library account? Click to login
Lip and Jaw Tremor in Parkinson’s Disease Cover

Lip and Jaw Tremor in Parkinson’s Disease

Open Access
|Apr 2025

Figures & Tables

Table 1

Contrasting features between Parkinson’s disease patients with and without jaw tremor.

JAW TREMOR PRESENCE n = 39 (%)JAW TREMOR ABSENCE n = 190 (%)P-VALUE
Sex (male)22 (56.4)108 (56.8)0.960
Age (years)70.77 ± 11.2267.17 ± 10.990.065
Evolution time (years)8.19 ± 8.436.27 ± 6.140.100
Cognitive status (MoCA)21.06 ± 5.3621.69 ± 5.830.668
MDS-UPDRS-III (subscores)
    Language0.92 ± 1.090.96 ± 1.050.829
    Facial expression1.44 ± 1.021.09 ± 0.920.036
    Rigidity composite score9.33 ± 4.867.05 ± 4.030.002
    Bradykinesia composite score18.38 ± 9.7713.02 ± 9.090.001
    Rising from chair (3.9)1.51 ± 1.621.18 ± 2.390.406
    Gait (3.10)2.08 ± 1.271.69 ± 1.160.061
    Freezing (3.11)0.79 ± 1.510.66 ± 1.240.540
    Postural stability (3.12)2.15 ± 1.251.50 ± 1.170.002
    Posture (3.13)1.59 ± 1.141.17 ± 0.950.018
    Postural tremor (composite score)2.08 ± 1.861.06 ± 1.33<0.001
    Kinetic tremor (composite score)1.56 ± 1.680.97 ± 1.220.010
    Rest tremor (composite score)4.97 ± 3.461.85 ± 2.31<0.001
    Tremor persistence3.03 ± 0.8731.25 ± 1.38<0.001
    Total score52.56 ± 22.8934.53 ± 17.52<0.001
Hoehn-Yahr scale (modified)3.62 ± 0.963.17 ± 0.880.005
Dyskinesia presence, n (%)5 (12.8)28 (14.7)0.952 cc
Treatment
    Levodopa/carbidopa, n (%)24 (61.5)115 (60.5)0.966
    Amantadine, n (%)4 (10.3)13 (6.8%)0.502
    Dopamine agonists, n (%)10 (25.6)52 (27.4)0.981
    Anticholinergic, n (%)5 (12.8)11 (5.8)0.159
    MAOI, n (%)2 (5.1)20 (10.5)0.385
LEDD458.3 ± 425.5595.1 ± 632.60.101

[i] LEDD: Levodopa equivalent daily dose; MAOI: Monoamine oxidase inhibitor.

Table 2

Multivariate analysis of statistically significant variables in the bivariate analysis.

VARIABLES IN THE FINAL REGRESSION MODELEXPB COEFFICIENTEXPB 95% C.I.P-VALUE
Age1.0350.996–1.0760.075
MDS-UPDRS-III score1.0291.007–1.0510.009
Rest tremor composite score1.3831.197–1.597<0.001

[i] Constant: B-6.220, ExpB: 0.00, P < 0.001. Hosmer-Lemeshow: (P = 0.299). Nagelkerke R2 = 0.323. Variables not included in the final equation: Hoehn-Yahr scale, postural tremor composite score, kinetic tremor composite score, facial expression, bradykinesia composite score, rigidity composite score, postural stability and posture, scores. MDS-UPDRS-III: Movement Disorders Society Unified Parkinson’s Disease Rating Scale, part III.

Table 3

Contrasting clinical features of rhythmic repetitive lip/jaw movements.

PARKINSON’S JAW TREMORESSENTIAL JAW TREMORJAW CLONUSGENIOSPASMRABBIT SYNDROMETASK-SPECIFIC JAW TREMORMYORHYTHMIATARDIVE PHENOMENA
EtiologyPD and other parkinsonian syndromesEssential tremorALS, NMO, ODMostly hereditary, isolated in few casesDrug-induced by DRBUnknowStroke, infections (WpD), autoimmuneTardive dyskinesia or tremor (DRB and other drugs)
Prevalence within specific cause17–18%7.5 to 18%RareAll cases by definition2.3 to 4.4%RareRareCommon (dyskinesia), tremor (uncommon)
Type of movementJaw and lip rest tremor, postural and kinetic component are less commonJaw tremor is usually postural or kineticElicited by testing the jaw-jerk reflex or by jaw openingRhythmic or irregular twitch-like chin quivering or trembling in bouts lasting minutes to hoursVertical mouth and lip movements, without tongue involvementJaw tremor triggered with a specific task (i.e., drinking water)Continuous central facial rhythmic movements, + nystagmus, palatal, limb movements (OMM)Repetitive masticatory movements or jaw tremor + lingual, limb or axial stereotypies
Movement frequency (Hz)3–5 Hz4–12 Hz~ 10 Hz5–6 Hz~ 5 Hz5–8 Hz1–4 Hz1–2 Hz
Clinical correlates and/or comorbid conditionsOlder age, greater limb rest tremor severity, higher motor scoresOlder age, presence of head and voice tremor, greater arm tremor severity, rest tremor in the arms.Upper motor lesion above the spinal cordFamily history (Autosomal dominant pattern). RNTBUnderlying schizophrenia, bipolar disorder, Korsakoff’s sx, etc.
Some have parkinsonism
Some may improve with alcohol, or alleviating maneuvers (i.e., sensory tricks)SnGP, arthralgia, diarrhea, weight loss or focal deficits depending on the causeAssociated psychiatric disorders.
Some have parkinsonism
TreatmentLevodopa, dopamine agonists, Achol, BoNTPropranolol, primidone, topiramate, BoNTBaclofen, tizanidine, BZD, BoNTBoNT; BZD for RNTB↓ DRB or withdrawal, AcholBoNTTreat underlying cause, i.e., Abs for WpD↓ DRB or withdrawal, TBZ, VBZ, deuTBZ

[i] Abs: antibiotics; Achol: anticholinergics (benzatropine, procyclidine, trihexyphenidyl, etc.); ALS: amyotrophic lateral sclerosis; BoNT: botulinum toxin; BZD: benzodiazepines; deuTBZ: deutetrabenazine; DRB: Dopamine receptor blockers; NMO: neuromyelitis optica; OD: osmotic demyelination; OMM: oculomasticatory myorhythmia; PD: Parkinson’s disease; RNTB: Recurrent nocturnal tongue biting; SnGP: supranuclear gaze palsy; Sx: syndrome; TBZ: tetrabenazine; VBZ: valbenazine; WpD. Whipple disease.

DOI: https://doi.org/10.5334/tohm.1001 | Journal eISSN: 2160-8288
Language: English
Submitted on: Jan 25, 2025
Accepted on: Apr 4, 2025
Published on: Apr 14, 2025
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2025 José Fidel Baizabal-Carvallo, Marlene Alonso-Juarez, Robert Fekete, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.